Functional organization of mammalian hexokinases: Characterization of the rat type III isozyme and its chimeric forms, constructed with the N- and C-terminal halves of the type I and type II isozymes

被引:41
作者
Tsai, HJ [1 ]
Wilson, JE [1 ]
机构
[1] MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824
关键词
hexokinase; type III isozyme; mammalian isozymes of; mammalian; evolution of; functional organization of; proteins; chimeric;
D O I
10.1006/abbi.1996.9850
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies have shown that catalytic function is associated with both halves of the Type II isozyme of mammalian hexokinase, while the Type I isozyme is functionally differentiated into a catalytic C-terminal half and regulatory N-terminal half. The Type III isozyme has now been shown to be similar to the Type I isozyme in its functional organization. Chimeras composed of the N-terminal half of Type III hexokinase and the C-terminal half of either Type I or Type II hexokinase have activities that can be attributed to the C-terminal half and are similar in activity to chimeras composed of the C-terminal half of Type III and the intrinsically inactive N-terminal domain of Type I or the inactivated (by site-directed mutation) N-terminal half of Type II hexokinase. Virtually no activity was seen with chimeras constructed with the N-terminal half of the Type III isozyme and catalytically inactive (by site-directed mutation) C-terminal halves of Type I or Type II hexokinase. Substrate inhibition by Glc is seen only with the Type III isozyme and with chimeric forms containing the C-terminal half of Type m hexokinase and the N-terminal half of Type I or Type II isozyme, the latter inactivated by site-directed mutation; this is attributed to conformational changes induced by binding of Glc to a low affinity site in the N-terminal half, with subsequent effect on catalytic activity of the C-terminal half. These results also provide further insight into the role of interactions (or lack of interactions) between the N- and C-terminal halves in the inhibition of the Type I-III isozymes by Glc-6-P, its antagonism by low concentrations of P-i, and the inhibition seen at higher concentrations of P-i. (C) 1997 Academic Press.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 33 条
[1]   Crystallization and preliminary X-ray analysis of human brain hexokinase [J].
Aleshin, AE ;
Zeng, CB ;
Fromm, HJ ;
Honzatko, RB .
FEBS LETTERS, 1996, 391 (1-2) :9-10
[2]   Functional organization of mammalian hexokinase II - Retention of catalytic and regulatory functions in both the NH2- and COOH-terminal halves [J].
Ardehali, H ;
Yano, Y ;
Printz, RL ;
Koch, S ;
Whitesell, RR ;
May, JM ;
Granner, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :1849-1852
[3]   Purification and characterization of the hexokinase from Schistosoma mansoni, expressed in Escherichia coli [J].
Armstrong, RL ;
Wilson, JE ;
Shoemaker, CB .
PROTEIN EXPRESSION AND PURIFICATION, 1996, 8 (03) :374-380
[4]  
ARORA KK, 1993, J BIOL CHEM, V268, P18259
[5]  
ARORA KK, 1991, J BIOL CHEM, V266, P5359
[6]   RESIDUES PUTATIVELY INVOLVED IN BINDING OF ATP AND GLUCOSE-6-PHOSPHATE TO A MAMMALIAN HEXOKINASE - SITE-DIRECTED MUTATION AT ANALOGOUS POSITIONS IN THE N-TERMINAL AND C-TERMINAL HALVES OF THE TYPE-I ISOZYME [J].
BAIJAL, M ;
WILSON, JE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 321 (02) :413-420
[7]   FUNCTIONAL CONSEQUENCES OF MUTATION OF HIGHLY CONSERVED SERINE RESIDUES, FOUND AT EQUIVALENT POSITIONS IN THE N-TERMINAL AND C-TERMINAL DOMAINS OF MAMMALIAN HEXOKINASES [J].
BAIJAL, M ;
WILSON, JE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 298 (01) :271-278
[8]   TRANSLOCATION IN YEAST AND MAMMALIAN-CELLS - NOT ALL SIGNAL SEQUENCES ARE FUNCTIONALLY EQUIVALENT [J].
BIRD, P ;
GETHING, MJ ;
SAMBROOK, J .
JOURNAL OF CELL BIOLOGY, 1987, 105 (06) :2905-2914
[9]   RAT-BRAIN HEXOKINASE - GLUCOSE AND GLUCOSE-6-PHOSPHATE BINDING-SITES AND C-TERMINAL AMINO-ACID OF PURIFIED ENZYME [J].
CHOU, AC ;
WILSON, JE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1974, 165 (02) :628-633
[10]  
ELLISON WR, 1975, J BIOL CHEM, V250, P1864